The Genetic Testing Conundrum

The Genetic Testing Conundrum

  • July 28, 2017

By Lynanne B. Morganstern, MD, MBA Medical Director, InterQual Care Planning Genetic tests are revolutionizing more than medicine. They’re revolutionizing the doctor-patient experience as they increasingly become a consumer-driven service. And that’s raising questions for providers and challenges for payers. The direct-to-consumer 23andMe DNA test kit was FDA-approved in early April. For $200, anyone can order a test that reports on genetic markers for certain health conditions, and genetic variants for certain health conditions’ carrier status. For just $50 more, consumers can order the Color test panel which looks at 30 genes to provide a risk assessment for common hereditary…

Read More
McKesson Entity Now Change Healthcare

McKesson Entity Now Change Healthcare

  • May 6, 2017

McKesson Technology Solutions and Change Healthcare have merged to create a new healthcare information technology company. The new Change Healthcare includes all of Change Healthcare's businesses and the majority of McKesson Technology Solutions, and will employ about 15,000 people. Read the article

Read More